{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:20:21Z","timestamp":1765545621772,"version":"3.37.3"},"reference-count":68,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.neuropharm.2010.07.004","type":"journal-article","created":{"date-parts":[[2010,7,12]],"date-time":"2010-07-12T00:57:05Z","timestamp":1278896225000},"page":"492-502","source":"Crossref","is-referenced-by-count":21,"title":["The H3 antagonist, ciproxifan, alleviates the memory impairment but enhances the motor effects of MK-801 (dizocilpine) in rats"],"prefix":"10.1016","volume":"59","author":[{"given":"Mark E.","family":"Bardgett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Points","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Kleier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meredith","family":"Blankenship","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molly S.","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2010.07.004_bib1","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1046\/j.1460-9568.2002.02005.x","article-title":"Endogenous histamine in the medial septum-diagonal band complex increases the release of acetylcholine from the hippocampus: a dual-probe microdialysis study in the freely moving rat","volume":"15","author":"Bacciottini","year":"2002","journal-title":"European Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib2","doi-asserted-by":"crossref","first-page":"8394","DOI":"10.1523\/JNEUROSCI.18-20-08394.1998","article-title":"Multiple limbic regions mediate the disruption of prepulse inhibition produced in rats by the noncompetitive NMDA antagonist dizocilpine","volume":"18","author":"Bakshi","year":"1998","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib3","series-title":"Atypical Antipsychotics: from Bench to Bedside","first-page":"61","article-title":"Behavioral models of atypical antipsychotic drug action","author":"Bardgett","year":"2004"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib4","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.neuropharm.2006.07.014","article-title":"Effects of risperidone on locomotor activity and spatial memory in rats with hippocampal damage","volume":"51","author":"Bardgett","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0361-9230(03)00023-6","article-title":"NMDA receptor blockade and hippocampal neuronal loss impair fear conditioning and position habit reversal in C57Bl\/6 mice","volume":"60","author":"Bardgett","year":"2003","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0166-4328(96)00132-5","article-title":"Kainic acid lesions enhance locomotor responses to novelty, saline, amphetamine, and MK-801","volume":"84","author":"Bardgett","year":"1997","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.nlm.2005.08.010","article-title":"The effects of clozapine on delayed spatial alternation deficits in rats with hippocampal damage","volume":"85","author":"Bardgett","year":"2006","journal-title":"Neurobiology of Learning and Memory"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib8","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1038\/sj.npp.1301580","article-title":"The effects of clonidine on discrete-trial delayed spatial alternation in two rat models of memory loss","volume":"33","author":"Bardgett","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib9","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00213-009-1566-8","article-title":"Effects of the H3 receptor antagonist, thioperamide, on behavioral alterations induced by systemic MK-801 administration","volume":"205","author":"Bardgett","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s002130050587","article-title":"Effects of drugs of abuse and scopolamine on memory in rats: delayed spatial alternation and matching to position","volume":"137","author":"Baron","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbr.2004.02.017","article-title":"Histamine H3 antagonist thioperamide dose-dependently enhances memory consolidation and reverses amnesia induced by dizocilpine or scopolamine in a one-trial inhibitory avoidance task in mice","volume":"154","author":"Bernaerts","year":"2004","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1006\/nlme.2001.4025","article-title":"Hippocampal theta oscillations and classical conditioning","volume":"76","author":"Berry","year":"2001","journal-title":"Neurobiology of Learning and Memory"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib13","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.bcp.2006.10.031","article-title":"Histamine H3 receptor antagonists: from target identification to drug leads","volume":"73","author":"Bonaventure","year":"2007","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00213-008-1345-y","article-title":"Effects of the H3 receptor inverse agonist thioperamide on cocaine-induced locomotion in mice: role of the histaminergic system and potential pharmacokinetic interactions","volume":"202","author":"Brabant","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib15","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0091-3057(95)02073-X","article-title":"Acute behavioral effects of MK-801 in the mouse","volume":"53","author":"Brosnan-Watters","year":"1996","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bbr.2003.11.001","article-title":"Enhancement of prepulse inhibition of startle in mice by the H3 receptor antagonists thioperamide and ciproxifan","volume":"153","author":"Browman","year":"2004","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib17","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/sj.npp.1300678","article-title":"Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists","volume":"30","author":"Chartoff","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib18","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1476-5381.1992.tb13386.x","article-title":"Histamine H3 receptors modulate the release of [3H]-acetylcholine from slices of rat entorhinal cortex: evidence for the possible existence of H3 receptor subtypes","volume":"107","author":"Clapham","year":"1992","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(94)90498-7","article-title":"Thioperamide, the selective histamine H3 receptor antagonist, attenuates stimulant-induced locomotor activity in the mouse","volume":"259","author":"Clapham","year":"1994","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0306-4522(02)00415-3","article-title":"Distinct pattern of c-fos mRNA expression after systemic and intra-accumbens amphetamine and MK-801","volume":"115","author":"De Leonibus","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00213-003-1467-1","article-title":"Flumazenil and tacrine increase the effectiveness of ondansetron on scopolamine-induced impairment of spatial learning in rats","volume":"169","author":"Diez-Ariza","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.neuroscience.2009.03.038","article-title":"Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models","volume":"161","author":"Engin","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib23","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1124\/jpet.102.047183","article-title":"Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effects","volume":"305","author":"Esbenshade","year":"2003","journal-title":"Journal of Pharmacological and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0091-3057(98)00128-2","article-title":"Ceruletide inhibits phencyclidine-induced dopamine and serotonin release in rat prefrontal cortex","volume":"61","author":"Etou","year":"1998","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib25","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/j.1471-4159.2006.04002.x","article-title":"N-methyl-d-aspartate receptor antagonists enhance histamine neuron activity in rodent brain","volume":"98","author":"Faucard","year":"2006","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neuropharm.2008.05.008","article-title":"Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal function","volume":"55","author":"Ferrada","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib27","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1124\/jpet.102.047241","article-title":"Two novel and selective nonimidazole H3 receptor antagonists A-304121 and A-317920: II. In vivo behavioral and neurophysiological characterization","volume":"305","author":"Fox","year":"2003","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib28","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1124\/jpet.104.078402","volume":"313","author":"Fox","year":"2005","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib29","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.neuropharm.2009.03.011","article-title":"JNJ-10181457, a selective non-imidazole histamine H3 receptor antagonist, normalizes acetylcholine neurotransmission and has efficacy in translational rat models of cognition","volume":"56","author":"Galici","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbr.2007.06.012","article-title":"Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat","volume":"184","author":"Grayson","year":"2007","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1124\/jpet.107.130070","article-title":"Modulation of hippocampal theta oscillation by histamine H3 receptors","volume":"324","author":"Haj\u00f3s","year":"2008","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib32","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/BF01271225","article-title":"Role of dopaminergic neuronal system in dizocilpine-induced acetylcholine release in the rat brain","volume":"103","author":"Hasegawa","year":"1996","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib33","doi-asserted-by":"crossref","first-page":"11496","DOI":"10.1523\/JNEUROSCI.2213-07.2007","article-title":"NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons","volume":"27","author":"Homayoun","year":"2007","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib34","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbr.2003.09.002","article-title":"Effect of the histamine H3-antagonist clobenpropit on spatial memory deficits induced by MK-801 as evaluated by radial maze in Sprague-Dawley rats","volume":"151","author":"Huang","year":"2004","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib35","doi-asserted-by":"crossref","first-page":"8467","DOI":"10.1073\/pnas.0308455101","article-title":"NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex","volume":"101","author":"Jackson","year":"2004","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0165-3806(00)00059-6","article-title":"Maturation of locomotor and Fos responses to NMDA antagonists, PCP and MK-801","volume":"122","author":"Jacobs","year":"2000","journal-title":"Developmental Brain Research"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib37","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.104.075887","article-title":"Pharmacologic interactions between the muscarinic cholinergic and dopaminergic systems in the modulation of prepulse inhibition in rats","volume":"312","author":"Jones","year":"2005","journal-title":"Journal of Pharmacological & Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib38","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/bja\/83.6.945","article-title":"Inhibitory effect of clonidine on ketamine-induced norepinephrine release from the medial prefrontal cortex in rats","volume":"83","author":"Kubota","year":"1999","journal-title":"British Journal of Anaesthesia"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib39","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1124\/jpet.107.135343","article-title":"Correlation between ex vivo receptor occupancy and wake-promoting activity of selective H3 receptor antagonists","volume":"325","author":"Le","year":"2008","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib40","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.bcp.2007.01.023","article-title":"Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649","volume":"73","author":"Ligneau","year":"2007","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib41","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0022-3565(24)37840-1","article-title":"Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist","volume":"287","author":"Ligneau","year":"1998","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1124\/jpet.106.111039","article-title":"BF2.649 [1-{3-[3-4-Chlorophenylpropoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist\/antagonist at the human histamine H3 receptor: preclinical pharmacology","volume":"320","author":"Ligneau","year":"2007","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0893-133X(02)00282-8","article-title":"Neonatal damage of the ventral hippocampus impairs working memory in the rat","volume":"27","author":"Lipska","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib44","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/sj.npp.1300238","article-title":"Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge","volume":"28","author":"Lorrain","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib45","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nature08010","article-title":"Hippocampal theta oscillations are travelling waves","volume":"459","author":"Lubenov","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib46","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1017\/S1461145705005328","article-title":"Combined alpha2 and D2\/3 receptor blockade enhances cortical glutamatergic transmission and reverses cognitive impairment in the rat","volume":"8","author":"Marcus","year":"2005","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib47","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/FBP.0b013e3282ee82e3","article-title":"Elicited hippocampal theta rhythm: a screen for anxiolytic and procognitive drugs through changes in hippocampal function?","volume":"18","author":"McNaughton","year":"2007","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib48","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1124\/jpet.107.120311","article-title":"GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer\u2019s disease brain and improves cognitive performance in preclinical models","volume":"321","author":"Medhurst","year":"2007","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2008.05.005","article-title":"Erythropoietin improves spatial delayed alternation in a T-maze in rats subjected to ablation of the prefrontal cortex","volume":"77","author":"Mogensen","year":"2008","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib50","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.281.5381.1349","article-title":"Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats","volume":"281","author":"Moghaddam","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(97)01445-5","article-title":"Involvement of medial septal glutamate and GABAA receptors in behaviour-induced acetylcholine release in the hippocampus: a dual probe microdialysis study","volume":"789","author":"Moor","year":"1998","journal-title":"Brain Research"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib52","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/jpet.300.2.621","article-title":"Acute and chronic effects of methamphetamine on tele-methylhistamine levels in mouse brain: selective involvement of the D(2) and not D(3) receptor","volume":"300","author":"Morisset","year":"2002","journal-title":"Journal of Pharmacological & Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib53","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00213-002-1004-7","article-title":"Effects of acute and repeated systemic administration of ketamine on prefrontal acetylcholine release and sustained attention performance in rats","volume":"161","author":"Nelson","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib54","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/archpsyc.1992.01820120063009","article-title":"Schizophrenics show spatial working memory deficits","volume":"49","author":"Park","year":"1992","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib55","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0306-4522(02)00135-5","article-title":"A detailed mapping of the histamine H(3) receptor and its gene transcripts in rat brain","volume":"114","author":"Pillot","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib56","doi-asserted-by":"crossref","first-page":"7272","DOI":"10.1523\/JNEUROSCI.22-16-07272.2002","article-title":"Ciproxifan, a histamine H3-receptor antagonist\/inverse agonist, potentiates neurochemical and behavioral effects of haloperidol in the rat","volume":"22","author":"Pillot","year":"2002","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib57","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejphar.2007.07.071","article-title":"Age-related differential sensitivity to MK-801-induced locomotion and stereotypy in C57BL\/6 mice","volume":"580","author":"Qi","year":"2008","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib58","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s002130100776","article-title":"Sensitization of prepulse inhibition deficits by repeated administration of dizocilpine","volume":"156","author":"Schulz","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib59","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00213-008-1310-9","article-title":"Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040","volume":"201","author":"Southam","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib60","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1124\/jpet.102.038422","article-title":"The group II metabotropic glutamate receptor agonist (-)-2-oxa-4-aminobicyclo[3.1.0.]hexane-4,6-dicarboxylate (LY379268) and clozapine reverse phencyclidine-induced behaviors in monoamine-depleted rats","volume":"303","author":"Swanson","year":"2002","journal-title":"Journal of Pharmacological and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib61","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1523\/JNEUROSCI.20-11-04325.2000","article-title":"Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists","volume":"20","author":"Swerdlow","year":"2000","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib62","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.pbb.2003.11.008","article-title":"Sensitivity to drug effects on prepulse inhibition in inbred and outbred rat strains","volume":"77","author":"Swerdlow","year":"2004","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib63","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1523\/JNEUROSCI.16-01-00373.1996","article-title":"NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine","volume":"16","author":"Verma","year":"1996","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib64","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1037\/a0013633","article-title":"NMDA receptor involvement in spatial delayed alternation in developing rats","volume":"123","author":"Watson","year":"2009","journal-title":"Behavioral Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib65","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0893-133X(00)00150-0","article-title":"WAY 100135, an antagonist of 5-HT1A serotonin receptors, attenuates psychotomimetic effects of MK-801","volume":"23","author":"Wedzony","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib66","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF02253717","article-title":"Behavioral effects of MK-801 in the rat","volume":"101","author":"Wozniak","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib67","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1101\/lm.850808","article-title":"Prefrontal cortex and hippocampus subserve different components of working memory in rats","volume":"15","author":"Yoon","year":"2008","journal-title":"Learning & Memory"},{"key":"10.1016\/j.neuropharm.2010.07.004_bib68","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.brainres.2005.03.018","article-title":"Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug-drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs","volume":"1045","author":"Zhang","year":"2005","journal-title":"Brain Research"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390810001656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390810001656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T20:42:25Z","timestamp":1740256945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390810001656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0028390810001656"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2010.07.004","relation":{},"ISSN":["0028-3908"],"issn-type":[{"type":"print","value":"0028-3908"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}